Literature DB >> 21256126

Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells.

Orkhontuya Tsedensodnom1, Hironori Koga, Stephen A Rosenberg, Sarah B Nambotin, John J Carroll, Jack R Wands, Miran Kim.   

Abstract

The Wnt/β-catenin signaling pathway is frequently activated in hepatocellular carcinoma (HCC). Downstream signaling events involving the Wnt/β-catenin cascade occur through T-cell factor (TCF) proteins. The human TCF-4 gene is composed of 17 exons with multiple alternative splicing sites. However, the role of different TCF-4 isoforms in the pathogenesis of HCC is unknown. The purpose of this study was to identify and characterize TCF-4 isoforms in HCC. We identified 14 novel TCF-4 isoforms from four HCC cell lines. Functional analysis following transfection and expression in HCC cells revealed distinct effects on the phenotype. The TCF-4J isoform expression produced striking features of malignant transformation characterized by high cell proliferation rate, migration and colony formation even though its transcriptional activity was low. In contrast, the TCF-4K isoform displayed low TCF transcriptional activity; cell proliferation rate and colony formation were reduced as well. Interestingly, TCF-4J and TCF-4K differed by only five amino acids (the SxxSS motif). Thus, these studies suggest that conserved splicing motifs may have a major influence on the transcriptional activity and functional properties of TCF-4 isoforms and alter the characteristics of the malignant phenotype.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21256126      PMCID: PMC3066145          DOI: 10.1016/j.yexcr.2011.01.015

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  37 in total

Review 1.  New aspects of diagnosis and therapy of hepatocellular carcinoma.

Authors:  J Bruix; A J Hessheimer; A Forner; L Boix; R Vilana; J M Llovet
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

2.  Hep G2 is a hepatoblastoma-derived cell line.

Authors:  Dolores López-Terrada; Sau Wai Cheung; Milton J Finegold; Barbara B Knowles
Journal:  Hum Pathol       Date:  2009-10       Impact factor: 3.466

3.  Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.

Authors:  Han Chu Lee; Bo Tian; John M Sedivy; Jack R Wands; Miran Kim
Journal:  Gastroenterology       Date:  2006-10       Impact factor: 22.682

4.  Down-regulation of death-associated protein kinase-2 is required for beta-catenin-induced anoikis resistance of malignant epithelial cells.

Authors:  Hongbing Li; Gibanananda Ray; Byong Hoon Yoo; Mete Erdogan; Kirill V Rosen
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

5.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

Authors:  M Shtutman; J Zhurinsky; I Simcha; C Albanese; M D'Amico; R Pestell; A Ben-Ze'ev
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

6.  Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.

Authors:  Miran Kim; Han Chu Lee; Orkhontuya Tsedensodnom; Rochelle Hartley; Young-Suk Lim; Eunsil Yu; Philippe Merle; Jack R Wands
Journal:  J Hepatol       Date:  2008-02-07       Impact factor: 25.083

7.  SiRNA of frizzled-9 suppresses proliferation and motility of hepatoma cells.

Authors:  Tatsuya Fujimoto; Minoru Tomizawa; Osamu Yokosuka
Journal:  Int J Oncol       Date:  2009-10       Impact factor: 5.650

8.  XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development.

Authors:  M Brannon; J D Brown; R Bates; D Kimelman; R T Moon
Journal:  Development       Date:  1999-06       Impact factor: 6.868

9.  Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc.

Authors:  Vanesa Muncan; Owen J Sansom; Leon Tertoolen; Toby J Phesse; Harry Begthel; Elena Sancho; Alicia M Cole; Alex Gregorieff; Ignacio Moreno de Alboran; Hans Clevers; Alan R Clarke
Journal:  Mol Cell Biol       Date:  2006-09-05       Impact factor: 4.272

10.  Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma.

Authors:  A Bengochea; M M de Souza; L Lefrançois; E Le Roux; O Galy; I Chemin; M Kim; J R Wands; C Trepo; P Hainaut; J-Y Scoazec; L Vitvitski; P Merle
Journal:  Br J Cancer       Date:  2008-06-24       Impact factor: 7.640

View more
  22 in total

Review 1.  Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.

Authors:  Catherine D Mao; Stephen W Byers
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

2.  Chronic Ethanol-Induced Impairment of Wnt/β-Catenin Signaling is Attenuated by PPAR-δ Agonist.

Authors:  Chelsea Q Xu; Suzanne M de la Monte; Ming Tong; Chiung-Kuei Huang; Miran Kim
Journal:  Alcohol Clin Exp Res       Date:  2015-04-23       Impact factor: 3.455

3.  Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma.

Authors:  Yoshito Tomimaru; Hironori Koga; Hirohisa Yano; Suzanne de la Monte; Jack R Wands; Miran Kim
Journal:  Liver Int       Date:  2013-05-08       Impact factor: 5.828

Review 4.  TCF/LEFs and Wnt signaling in the nucleus.

Authors:  Ken M Cadigan; Marian L Waterman
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

5.  Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism.

Authors:  L Norton; M Fourcaudot; M A Abdul-Ghani; D Winnier; F F Mehta; C P Jenkinson; R A Defronzo
Journal:  Diabetologia       Date:  2011-09-07       Impact factor: 10.122

6.  The SxxSS motif of T-cell factor-4 isoforms modulates Wnt/β-catenin signal activation in hepatocellular carcinoma cells.

Authors:  Yoshito Tomimaru; Hironori Koga; Tai Ho Shin; Chelsea Q Xu; Jack R Wands; Miran Kim
Journal:  Cancer Lett       Date:  2013-04-02       Impact factor: 8.679

Review 7.  Alternative splicing within the Wnt signaling pathway: role in cancer development.

Authors:  B Sumithra; Urmila Saxena; Asim Bikas Das
Journal:  Cell Oncol (Dordr)       Date:  2016-01-13       Impact factor: 6.730

8.  Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity.

Authors:  Yoshito Tomimaru; Chelsea Q Xu; Sarah B Nambotin; Tao Yan; Jack R Wands; Miran Kim
Journal:  Liver Int       Date:  2013-05-06       Impact factor: 5.828

9.  Novel common integration sites targeted by mouse mammary tumor virus insertion in mammary tumors have oncogenic activity.

Authors:  Hyoung H Kim; A Pieter J van den Heuvel; John W Schmidt; Susan R Ross
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

10.  Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling.

Authors:  Hironori Koga; Orkhontuya Tsedensodnom; Yoshito Tomimaru; Evan J Walker; Han Chu Lee; Kang Mo Kim; Hirohisa Yano; Jack R Wands; Miran Kim
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.